Clinical Research Directory
Browse clinical research sites, groups, and studies.
Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells - Intensive Care Unit
Sponsor: Vanderbilt University Medical Center
Summary
The purpose of this study is to understand how cells of the immune system use the common sugar glucose during critical illness. Investigators will intravenously infuse a non-radioactive carbon-13 glucose tracer into adult intensive care unit (ICU) participants over a few hours and collect immune cells from the blood to track uptake and usage of this glucose within these immune cells.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
25
Start Date
2026-11-01
Completion Date
2028-03-01
Last Updated
2026-09-09
Healthy Volunteers
No
Conditions
Interventions
13C6-Glucose
Compounded as 5% 13C6-glucose in water and given intravenously over 2-4 hours at a total dose of 10-25 grams.
Locations (1)
Vanderbilt University Medical Center
Nashville, Tennessee, United States